Hot Topics from Texas Pharmacy Association January 2023

From Texas Pharmacy Association:

To help our local affiliates share what’s going on with TPA at their monthly meetings and to foster stronger connections with TPA, the attached PowerPoint presentation is available for use at your meetings this month. You’re welcome to use this however you wish, such as presenting it on screen or having someone read highlights to the group. Knowing that you may still not be meeting in person, we’ve also attached a PDF file that you may wish to forward to your members instead.

This is NOT meant to be an exhaustive review of everything happening at TPA, just a high-level overview summarizing some recent activities, upcoming events, and encouraging involvement/member benefits. We are happy to hear that many of you find this helpful. As always, we welcome your feedback.

Download the PDF file .

Hot Topics from Texas Pharmacy Association December 2022

From Texas Pharmacy Association:

To help our local affiliates share what’s going on with TPA at their monthly meetings and to foster stronger connections with TPA, the attached PowerPoint presentation is available for use at your meetings this month. You’re welcome to use this however you wish, such as presenting it on screen or having someone read highlights to the group. Knowing that you may still not be meeting in person, we’ve also attached a PDF file that you may wish to forward to your members instead.

This is NOT meant to be an exhaustive review of everything happening at TPA, just a high-level overview summarizing some recent activities, upcoming events, and encouraging involvement/member benefits. We are happy to hear that many of you find this helpful. As always, we welcome your feedback.

Download the PDF file .

Hot Topics from Texas Pharmacy Association October 2022

From Texas Pharmacy Association:

To help our local affiliates share what’s going on with TPA at their monthly meetings and to foster stronger connections with TPA, the attached PowerPoint presentation is available for use at your meetings this month. You’re welcome to use this however you wish, such as presenting it on screen or having someone read highlights to the group. Knowing that you may still not be meeting in person, we’ve also attached a PDF file that you may wish to forward to your members instead.

This is NOT meant to be an exhaustive review of everything happening at TPA, just a high-level overview summarizing some recent activities, upcoming events, and encouraging involvement/member benefits. We are happy to hear that many of you find this helpful. As always, we welcome your feedback.

Download the PDF file .

DAPA Board Meeting Minutes

September 2, 2022 Board Meeting Minutes

August 25, 2022 Board Meeting Minutes

DAPA Board of Directors

August 25, 2022

Season’s 52, Plano

The meeting was called to order by president JoAh Lee @ 6:41 pm.  In attendance were Alan Nguyen, Mahsa Helforoush, Amber Myers, Ashley Chasse, Navid Sundrani, Jeff Loesch, Shari McDaniel, Aaron Gilbert, Kath Chisholm, Elizabeth Dong, and Kim Nguyen.  Emery Johnson and Christine Hong were on Zoom. Proxy from Mahdi Al Hallaq was received.  

Minutes were passed out.  A motion to approve was made by Jeff, seconded by Amber then passed.

We welcomed new Digital/Social Media committee member Christine.  And the new student liaisons are Mahsa and Alan.  

A goal for incoming new year is to increase memberships.  We will plan November as Membership Engagement Month. We looking for ways to increase tech members.  Each board member will look into Robert’s Rule of Order and will present their duties and responsibilities to the board.  In hoping to be more engage with the members during meetings, Mahdi is making name badges for board members.

Emery Johnson and Don Levine from the Financial Review and Auditing Committee has made a recommendation to include a line to label funds as a “Scholarship Donation Fund” which will not be limited only to scholarships if the funds are needed out of this line item. Emery explained that although the funds will be labeled as a Scholarship Fund, it will not be limited to that designation and will prevent possible auditing issues.  All the members of the Financial Review and Auditing Committee was not in full agreement and the Board requested additional information regarding the recommendation.  This recommendation deemed additional council and review by our current CPA whilst all members of the Financial Review and Auditing Committee plus President and Vice President are present.  This said meeting is to be held within the next 60 days from this meeting.

The treasurer’s report showed a balance of $48,890.39.  Credits include $280 scholarship donations & $3.59 interest.  Debits include $3000 in scholarships & $19.24 Paypal fees.  A motion to approve treasurer’s report was made Jeff, seconded by Ashley, then passed.

Vice president Amber has a financial group sponsor $750 for November, so DAPA will have to contribute additional money for that meeting.  It was discussed that we can use that meeting as a member engagement meeting also.  The amount to spend is tabled to next month.

Student liaisons Mahsa & Alan have a goal of increasing memberships and retention.  Kath previously ha career day at a local school so Elizabeth is trying to set a career “day/social” for pharmacy students either 1st Saturday of October or November.  Mahsa & Alan will post & send out to fellow students for that event.

Shari made a motion to change Social Event Committee to Social Events & Outreach Committee , seconded by Jeff then passed.

Digital & social media chair JoAh announced that we will join Techsoup, which is network for nonprofit organizations to have discounts for various companies.  One of the company is box.com/org will help us get digitized storage securely.  We will join box.com/org using the free accounts 1st then will upgrade to monthly plans if we need more storage.

Scholarship  Committee chair Ashley announced the scholarship recipients : Chloe Grabenhorst (TT), Faith Collum (TT), & Ted Sohn (UT).  Hopefully they will attend September meeting to be recognized. Introductory emails will be sent to all the schools starting 1st Friday of October.  Applications will open in  January and close in April.  In May committee will review the applicants then forward to board for discussion. Winners will be notified in June & receive fund in July.

Nominating Committee Emery & Don announced the incoming officers for 2022-2023 term:  Shari McDaniel – treasurer, Kim Nguyen – secretary, Ashley Chasse – director, Andrew Wall – director, Christine Hong – director, Brittany Aldridge – technician director.  Motion to approve was made by Jeff, seconded by Shari then passed.

Legislative  Committee chair Jeff  has no new updates.  Previously, discussions were made about test & treat, reimbursements, and doctor dispensing.

A motion to adjourn was made by Amber, seconded by Jeff then passed.

The meeting was adjourned at 8:31 pm.

DAPA Mentorship Program

Student/Pharmacist Mentorship Program

Mark your calendars!
We’re SUPER excited to launch our new Student/Pharmacist Mentorship Program and we’re SUPER excited to have you join us either as a Mentor or Mentee!
As a part of our DAPA membership engagement initiatives, we’re starting a student-pharmacist mentorship program as requested by our members.
The goal of this mentorship program is to connect our pharmacy students with pharmacists in their interested fields so the students can have a better insight in to their future career choices.
This will increase our DAPA membership engagement and have our pharmacy students to continue being DAPA/TPA members after graduation!
With much feedback, we saw the need and desire for local pharmacists to mentor pharmacy students as they navigate through the career-world of pharmacy. Our student liaisons, Mahsa Helforoush and Alan Linh Nguyen of Texas Tech University of Health Sciences Center, and Elizabeth Beard, PharmD, Co-Chair of the Social Events and Outreach Committee have volunteered and committed their time to make this event possible.
We’re very excited to support our local students to achieve their career goals and provide the best care to our patients in the community. With experienced pharmacist mentors, we can make a difference one patient, one legislator, one community at a time.
We’re in need of more pharmacists to join this initiative!
Be the positive influence on our future pharmacists and empower and educate them for the future of pharmacy. There is strength in numbers, and together we advance.

Click here to register
https://dallaspharmacy.org/dapamentorshipprogram/


#togetherweadvance #theresstrengthinnumbers


Successful September 2022 Kick-Off Meeting

What a successful DAPA Kick-Off meeting we had last night at Seasons-52 Plano! We had a full house of pharmacists, pharmacy technicians, and pharmacy students which was made possible by our sponsor, Mark Roy, of AbbVie and our board members. We had a great engaging presentation from Dr. Yazdani of Lubbock Spine Institute on Qulipta and Urelvy. 
.
We proceeded to have the installation of officers and directors of the board which was conducted by our own past-president and long time supporter of DAPA, Chris Dembny
.
Our Kick Off announcements from DAPA’s President, Jo Ah Lee PharmD, MBA, included this year’s initiatives of DAPA of increasing memberships, student engagements, and membership engagements with DAPA. The President has also announced that November will be DAPA’s Membership Engagement month where we encourage everyone to be DAPA/ @texaspharmacyassociation members. 
.
In light of DAPA’s Membership Engagement Month, our Student Liaisons, Mahsa Helforoush, Alan Linh Nguyen and Social Events and Outreach Committee co-chair, Elizabeth Beard announced the launch of DAPA’s new program: Student-Pharmacist Mentorship Program which will be held on November 19. We encourage everyone to join us at the event to have an opportunity to be a mentor/mentee and increase pharmacy graduate memberships for DAPA/TPA! 
.
Following our news-packed announcements, our 2022 Scholarship Winners were announced: 

Chloe Grabenhorst
Texas Tech University Health Sciences Center 
Pharm.D. Candidate 2025
Faith Collum
Texas Tech University Health Sciences Center 
Pharm.D. Candidate 2025
Ted Sohn, PharmD
The University of Texas at Austin College of Pharmacy 
Pharm.D. Graduate 2022
.
We want to thank all of our members for their support of DAPA and we hope to see you soon in our next meeting on October 6 sponsored by Amgen at Maggiano’a Italy in Plano! 
.
#dallasareapharmacyassociation#dapa#dallasarea#dfwpharmacists#dallaspharmacy#dallaspharmacist#dallaspharmacystudents#dallaspharm#dfwpharmacystudents#texaspharmacy#texaspharmacyassociation

Scholarship Match Campaign

DAPA’s Past-President, Emery Johnson, challenges YOU, our members and participants,
to our Scholarship Match Campaign.

He has offered to MATCH up to $500 of donations until the end of February 2022!

This will allow us to have a total of $1000 additional funds for our scholarship winning students!

The Dallas Area Pharmacy Association has been recognizing pharmacy students since 2012, shaping the future of our profession. We are pleased to be able to award scholarships to undergraduates and recent PharmD graduates students that are invested in advocating for their profession and educating their communities.

Your generous gift of any size is a great way to help and encourage our pharmacy students to achieve their goals.

Click here to donate any amount.

DAPA & AbbVie Would Like to Invite You to the Women’s Health Sessions

Scroll down to choose your session!

SESSION ONE.
Wednesday, June 23 at 6 PM CST.
Endometriosis and Elagolix, indicated for moderate to severe endometriosis pain.

One of the most common gynecologic disorders in the U.S., and affecting  roughly 10% (190 million) of reproductive age women and girls worldwide, endometriosis is a highly estrogen-dependent, chronic, inflammatory disease characterized by the growth of endometrial tissue (similar to the lining of the uterus) outside the uterus, causing pain and/or infertility. ORILISSA (Elagolix)represents the first FDA-approved gonadotropin releasing hormone receptor antagonist in the market, and oral treatment for the management of moderate to severe pain associated with endometriosis in over a decade.

This presentation will provide a brief overview of endometriosis disease state, and clinical trial data for Elagolix, indicated for moderate to severe endometriosis pain (FDA approved July 2018). https://www.rxabbvie.com/pdf/orilissa_pi.pdf

 

SESSION TWO.
Thursday, June 24 at 6 PM CST.
UTERINE FIBROIDS & Elagolix+Estradiol/NETA, indicated for heavy menstrual bleeding associated with uterine leiomyomas in pre-menopausal women

Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids have been primarily managed by surgery and are the leading reason for the hysterectomies performed in the U.S. ORIAHNN (Elagolix+Estradiol/NETA) is the first FDA-approved non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

This presentation will provide a brief scientific overview of disease state and clinical trial data for Elagolix+E2/NETA, indicated for heavy menstrual bleeding associated with fibroids (FDA approved May 2020). https://www.rxabbvie.com/pdf/oriahnn_pi.pdf

Click on the date you’d like to join us to register for this event!

Wednesday, March 31, at 6 PM CST

Thursday, April 1, at 12:30 PM CST


Dear DAPA members,

The AbbVie Women’s Health Organization is pleased to connect with the community of Pharmacists in the Dallas area.

We recognize your pharmacies provide services that cover a wide variety of medications, for diverse disease states, patient monitoring, and frequent communications with a diversity of healthcare providers. We as MSLs work to advance R&D in Women’s Health, promoting scientific communications that are fair and balanced and non-promotional in nature. We are here to support all healthcare providers, including pharmacists, deliver the best care to their patients!

Uterine fibroids, also called leiomyomas, are estrogen and progesterone-dependent non-cancerous tumors of the uterus and are the most common type of benign tumor in women of reproductive age. Traditionally, uterine fibroids have been primarily managed by surgery and are the leading reason for the hysterectomies performed in the U.S. ORIAHNN (Elagolix+Estradiol/NETA) is the first FDA-approved non-surgical, oral medication option for the management of heavy menstrual bleeding associated with uterine fibroids in pre-menopausal women.

With the ultimate goal to bring awareness, and elevate Women’s healthcare and the scientific acumen of our healthcare givers in our community, I will be offering a virtual educational program to connect with all of you, and provide a brief overview of uterine fibroids disease state and the phase III clinical trial data supporting our newest product indicated for heavy menstrual bleeding associated with uterine fibroids (FDA approved in 2020, https://www.rxabbvie.com/pdf/oriahnn_pi.pdf)

I will be offering two options for you to join via zoom,

Wed Mar 31, at 6 pm CT

Thurs April 1, at 12:30 pm CT

I look forward to having you join!

As your local MSL, please count on me as your local scientific peer and resource.

Thank you for your devoted service to all our patients,

Respectfully,

Maria J. Torres, PhD

Medical Science Liaison – Women’s Health | TX MS LA

Women’s Health MSL Organization

US Medical Affairs


BIO: Maria Jose Torres, PhD

Dr. Torres brings 10 years of academic research experience in the Women’s Health arena with a focus on estrogens and estrogen-dependent disease. She completed her bachelor’s degree in Biochemistry in her home country, Uruguay, and then moved to the United States to pursue her Doctorate in Bioenergetics at East Carolina University. Her research work, discovering novel non-genomic mechanisms of metabolic control by estrogens impacted by menopause was published in the top journal Cell, and she was soon recruited to Duke University. Working at the Duke Molecular Physiology Institute, she was a Duke Scholar in Molecular Medicine, she received a Postdoctoral Fellowship through the American Heart Association, and was the developer and leader of a clinical-translational research program to investigate the long-term cardiometabolic toxicity of chemotherapy in breast cancer survivors.

Mission-driven to advance Women’s Health research and healthcare, Dr. Torres recently joined the AbbVie Women’s Health Organization as a Medical Science Liaison, supporting the territory o